Inhaled chronic obstructive pulmonary disease (COPD) medications prescribed before surgery in patients with early-stage non–small cell lung cancer (NSCLC) were associated with both short- and ...

Leah J. Witt, MD: Hello. I'm Dr Leah Witt. Welcome to season one of Medscape InDiscussion, chronic obstructive pulmonary disease (COPD) podcast series. Today we're talking medications, especially ...

Please provide your email address to receive an email when new articles are posted on . Less than 40% of the studied veteran cohort were adherent to their inhaled COPD medications. Adherence was found ...

The inhalation formulation is expected to deliver treatment directly to the lungs, reducing the potential for systemic toxicity. The Food and Drug Administration (FDA) has granted Fast Track ...

If only managing a patient with an obstructive lung disease — like asthma or chronic obstructive pulmonary disease (COPD) — were as easy as writing a prescription. As it stands now, physicians also ...

The analysis included 96 consecutive patients with a diagnosis of COPD and hospitalized in the internal medicine division between August 2022 and April 2023. HealthDay News — Among patients ...

The European Medicines Agency (EMA) has released a guideline on assessing the quality of inhaled and nasal medicines, as well as a guideline on demonstrating therapeutic equivalence (TE) of orally ...

Rentosertib inhalation solution is the 13th program from Insilico's AI-driven pipeline to receive IND clearance, further demonstrating how Pharma.AI could reproducibly drive the discovery and ...

Xopenex (levalbuterol) is a brand-name inhaled medication prescribed to treat and help prevent difficulty breathing associated with bronchospasm. Xopenex comes in two forms: a solution for use with a ...